ROBE

Company Overview

Snapshot

Founded in January 2023, ROBE operates with 1–10 employees. The company has secured seed funding across one disclosed round, totaling $650,000. ROBE holds a patent for its advanced system designed for patient repositioning.

Business overview

ROBE develops an advanced, patented system to prevent bedsores and edema in bedridden patients. This technology allows for safe and gentle patient repositioning, activatable with a button press or automatically. The system aims to enhance patient independence, including in home hospitalization settings, and offers hospitals benefits such as improved reputation for high-quality care and cost savings by reducing the physical effort required for manual repositioning. ROBE operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Accessibility Solutions, with a core technology in Machinery & Robotics, targeting healthcare providers and patients in North America.

Company Intelligence Q&A

What is ROBE's primary focus?

ROBE's primary focus is on preventing bedsores and edema in bedridden individuals through an advanced, patented system for safe and gentle patient repositioning.

When was ROBE founded?

ROBE was founded in January 2023.

What is the core technology behind ROBE's solution?

ROBE's core technology involves a patented system that enables automated or on-demand patient repositioning, falling under the Machinery & Robotics classification.

Which markets does ROBE target?

ROBE targets the North American market, serving healthcare providers and patients.

What is the current stage of ROBE's product development?

ROBE's product is currently in the Customer Development stage, with a prototype demonstrated at a rehabilitation conference and interest from five major medical centers for pilot programs.